Canton Hathaway’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38K | Hold |
345
| – | – | 0.01% | 219 |
|
|
2025
Q1 | $39K | Hold |
345
| – | – | 0.01% | 217 |
|
|
2024
Q4 | $32K | Hold |
345
| – | – | 0.01% | 197 |
|
|
2024
Q3 | $29K | Hold |
345
| – | – | 0.01% | 211 |
|
|
2024
Q2 | $24K | Hold |
345
| – | – | 0.01% | 221 |
|
|
2024
Q1 | $25K | Hold |
345
| – | – | 0.01% | 220 |
|
|
2023
Q4 | $28K | Hold |
345
| – | – | 0.01% | 204 |
|
|
2023
Q3 | $26K | Hold |
345
| – | – | 0.01% | 202 |
|
|
2023
Q2 | $27K | Hold |
345
| – | – | 0.01% | 202 |
|
|
2023
Q1 | $29K | Hold |
345
| – | – | 0.01% | 186 |
|
|
2022
Q4 | $30K | Hold |
345
| – | – | 0.01% | 191 |
|
|
2022
Q3 | $21K | Hold |
345
| – | – | 0.01% | 212 |
|
|
2022
Q2 | $21K | Buy |
+345
| New | +$21K | 0.01% | 245 |
|
|
2022
Q1 | – | Sell |
-345
| Closed | -$25K | – | 251 |
|
|
2021
Q4 | $25K | Hold |
345
| – | – | 0.01% | 264 |
|
|
2021
Q3 | $24K | Buy |
+345
| New | +$24K | 0.01% | 265 |
|
|
2020
Q2 | – | Sell |
-564
| Closed | -$42K | – | 163 |
|
|
2020
Q1 | $42K | Buy |
+564
| New | +$42K | 0.03% | 101 |
|